Incannex Healthcare IXHL
NASDAQ IXHL
$3.31 +0.16 (+5.08%)
At close: Sep 29, 2026 · 4:00 PM EDT

Incannex Healthcare (IXHL) EBIT Margin (2024)

Updated

Incannex Healthcare (IXHL) recorded EBIT Margin of -27661.63% in FY2025 (year ended Jun 30, 2025), up 222680.04 percentage points from -250341.67% in FY2024.

Analysis

Incannex Healthcare (IXHL) EBIT Margin (2024) Analysis & Trends

Starting with FY2020, Incannex Healthcare's EBIT Margin history includes 4 fiscal years.

  • Annual EBIT Margin has a five-year change of -27338.24 percentage points (FY2020 to FY2025).
  • The FY2025 figure is the highest annual EBIT Margin since FY2021.
  • Per Business Quant data, IXHL's EBIT Margin was -250341.67% in FY2024 and -651.38% in FY2021 (-327.99 pp).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 28.21%
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 37.86%
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn -3.52%
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 32.97%
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 20.57%
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 34.95%
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn -133.21%
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 28.37%
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 37.40%
10 Incannex Healthcare 39.52 Mn 39.52 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 -41,700.00%
Sep 30, 2024 -8,451.35%
API Access

Incannex Healthcare EBIT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebit-margin&ticker=IXHL&period=max&api_key=YOUR_API_KEY